Iwanaga Eisaku

イワナガエイサク | Iwanaga Eisaku

Affiliation and department：
Job title： Assistant Professor

Research field (1)： Hematology and oncology

Research theme for competitive and other funds (2)：

2020 - 2023 急性骨髄性白血病におけるT細胞系転写因子ネットワークの解明
2017 - 2020 CEBPA遺伝子3’UTRメチル化を伴うMyeloid-T白血病の分子基盤の解明

Papers (12)：

Hiro Tatetsu, Miho Watanabe, Jun Liu, Kenji Tokunaga, Eisaku Iwanaga, Yoshihiro Komohara, Emily Thrash, Mahmoud A Bassal, Masao Matsuoka, Daniel G Tenen, et al. Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome. Clinical and translational medicine. 2023. 13. 8. e1327
Michihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, Naoki Watanabe, Shun Tsuchiya, Tomoiku Takaku, Noriyoshi Iriyama, Eriko Sato, Tomonori Nakazato, Toru Mitsumori, et al. Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. 2023
Mingrui Guo, Hon Man Tim Chan, Qi-Ling Zhou, Omer An, Ying Li, Yangyang Song, Zi Hui Tan, Hui En Vanessa Ng, Philomina Sona Peramangalam, Zhi Qing Tan, et al. Core binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. Blood. 2023. 141. 25. 3078-3090
Shun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, Noriyoshi Iriyama, Yuta Kimura, Eisaku Iwanaga, Kei-ji Sugimoto, Toru Mitsumori, Maho Ishikawa, Tomonori Nakazato, et al. Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice. Internal Medicine. 2023
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, et al. Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors. Annals of medicine. 2022. 54. 1. 1244-1254

ｍore...

MISC (17)：

岡本祐毅, 高木あゆ美, 上野志貴子, 岩永栄作, 樋口悠介, 遠藤慎也, 徳永賢治, 立津央, 野坂生郷, 安永純一朗, et al. A case of CVID manifested after severe infections and drug hypersensitivity. 日本血液学会学術集会抄録(Web). 2021. 83rd
立津央, 今金大輔, 遠藤慎也, 岩永栄作, 徳永賢治, 野坂生郷, 松岡雅雄. 再発時診断に苦慮した節外性NK/T細胞リンパ腫,鼻型の1例. 日本リンパ網内系学会会誌. 2020. 60
工藤ひまり, 立津央, 今金大輔, 上野志貴子, 岩永栄作, 野坂生郷, 松岡雅雄. 進行性の神経障害をきたしたIgG型リンパ形質細胞性リンパ腫の1例. 日本血液学会学術集会抄録(Web). 2020. 82nd
工藤ひまり, 井上明威, 山村綾子, 西村直, 遠藤慎也, 徳永賢治, 岩永栄作, 立津央, 野坂生郷, 松岡雅雄. 自家移植後早期再発DLBCLに対して同種造血細胞移植が奏功した一例. 日本造血細胞移植学会総会プログラム・抄録集. 2019. 41st. 228
藤岡功, 高久智生, 得平道英, 木村勇太, 岩永栄作, 杉元啓二, 仲里朝周, 入山規良, 佐藤恵理子, 石川真穂, et al. ニロチニブ治療患者における心血管系有害事象リスク因子に関する多施設共同後方視的研究(Analysis of cardiovascular risk factors in nilotinib-treated Japanese CML patients). 臨床血液. 2018. 59. 9. 1561-1561

ｍore...

Lectures and oral presentations (5)：

Outcomes of CML patients not achieving optimal response at one year of TKI treatment
(2023)
Corelative expression of oncofetal protein SALL4 and p53 in myelodysplastic syndrome(和訳中)
(日本血液学会学術集会 2021)
A case of diffuse large B-cell lymphoma in the course of Castleman's disease(和訳中)
(日本血液学会学術集会 2021)
A novel 17bp insertion between ABL exon 8/9 in a patient with refractory chronic myeloid leukemia(和訳中)
(日本血液学会学術集会 2021)
再発時診断に苦慮した節外性NK/T細胞リンパ腫、鼻型の1例
(日本リンパ網内系学会会誌 2020)

Professional career (1)：

PhD (Kumamoto University)

Work history (2)：

2014 - Kumamoto University University Hospital
2014 - Assistant Professor, ,University Hospital ,Kumamoto University

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page